Persistent URL of this record https://hdl.handle.net/1887/112481
In Collections
This item can be found in the following collections:
![A randomized, double-blinded, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATyR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
A randomized, double-blinded, placebo-controlled, multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, and biological activity of ATyR1940 in adult patients with facioscapulohumeral muscular dystrophy (FSHD)
- All authors
- Gershman, A.; Chiang, K.; M. do; Abbink, E.; Harbers, V.; Audebert, C.; Campana-Salort, E.; Monforte, M.; Iyadurai, S.; Carey, L.; Heskamp, L.; Kan, H.; Heerschap, A.; Kissel, J.; Ricci, E.; Attarian, S.; Blackburn, K.; Mendlein, J.; Ashlock, M.
- Date
- 2016-10-31
- Journal
- Neuromuscular Disorders
- Volume
- 26
- Pages
- S167 - S167